603882 金域醫學
按盤價 
30.490 +0.380 (+1.262%) | 2025/09 - 九個月 人民幣(K¥) | 與去年同期 比較 | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | ||
| 營業總收入 | 4,538,151 | -19.23% | 7,189,545 | 8,539,628 | 15,476,075 | 11,943,224 | |
| 減：營業總成本 | 4,282,603 | -16.32% | 6,748,751 | 7,635,231 | 11,942,260 | 9,158,116 | |
| 其中:營業成本 | 2,957,942 | -18.82% | 4,806,526 | 5,424,536 | 8,801,575 | 6,295,018 | |
| 財務費用 | (1,187) | 22.54% | (2,774) | (1,054) | (12,568) | 10,088 | |
| 資產減值損失 | (313) | -875.31% | (72,623) | 519 | 232 | (519) | |
| 公允價值變動收益 | -- | -- | (30,799) | -- | -- | -- | |
| 投資收益 | 3,658 | -171.40% | (37,083) | 262,967 | (10,800) | (7,295) | |
| 其中：對聯營企業和合營企業的投資收益 | 278 | -105.05% | (15,924) | (9,815) | (13,208) | (8,848) | |
| 營業利潤 | (63,006) | -157.17% | (273,244) | 759,762 | 3,347,234 | 2,776,768 | |
| 利潤總額 | (82,118) | -185.59% | (438,647) | 740,289 | 3,320,730 | 2,747,557 | |
| 減：所得稅費用 | 6,676 | -44.70% | (23,943) | 103,380 | 475,721 | 384,046 | |
| 淨利潤 | (88,794) | -205.87% | (414,704) | 636,909 | 2,845,009 | 2,363,512 | |
| 減：非控股權益 | (9,185) | -7.89% | (33,463) | (6,474) | 90,222 | 143,871 | |
| 股東淨利潤 | (79,610) | -184.84% | (381,241) | 643,382 | 2,754,787 | 2,219,640 | |
市場價值指標 | |||||||
| 每股收益 (元) * | -0.170 | -185.00% | -0.820 | 1.380 | 5.910 | 4.800 | |
| 每股派息 (元) * | -- | -- | 0.880 | 0.880 | 1.780 | 1.280 | |
| 每股淨資產 (元) * | 14.740 | -11.77% | 15.813 | 17.840 | 18.477 | 13.540 | |
| 審計意見 # | -- | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 14/11/2025 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
